Cite

HARVARD Citation

    Höflmayer, D. et al. (2020). Expression of CCCTC‐binding factor (CTCF) is linked to poor prognosis in prostate cancer. Molecular oncology. 14 (1), pp. 129-138. [Online]. 
  
Back to record